Skip to content

A real world study on TCM syndrome pattern and effective prescriptions of esophageal cancer

A real world study on TCM syndrome pattern and effective prescriptions of esophageal cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200061509
Enrollment
Unknown
Registered
2022-06-27
Start date
2022-07-01
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

Precancerous lesions of esophageal cancer:None
Early stage (I - III):None
Late stage (IV):None
Healthy control group:None

Sponsors

The Fourth Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Observation group: (1) Patients aged 18-75 years old; (2) Patients diagnosed by pathology as esophageal precancerous lesions and esophageal squamous cell carcinoma; (3) Estimated survival time >=3 months; (4) The patient was diagnosed for the first time and had not received any previous anti-tumor therapy; (5) No history of other malignant tumors; (6) No other metabolic diseases (such as hyperlipemia, diabetes, hyperthyroidism, hypothyroidism, etc.); (7) 12 hours before blood collection, abstain from drinking and fasting without taking any drugs; (8) No loss of basic information and pathological data; (9) Sign informed consent. 2. Healthy control group: No history of esophageal cancer and other malignant tumors, other criteria are the same as above.

Exclusion criteria

Exclusion criteria: 1. Complicated with serious underlying diseases; 2. Abnormal coagulation.

Design outcomes

Primary

MeasureTime frame
TCM syndrome pattern;Intestinal flora;Body fluid volume;

Secondary

MeasureTime frame
Blood routine examination;Non-target metabolomicsmetabolomics;

Countries

China

Contacts

Public ContactLi Jing

The Fourth Hospital of Hebei Medical University

lijingtiger@163.com+86 13931893011

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026